Dataset Information


The effect of 1 mg folic acid supplementation on clinical outcomes in female migraine with aura patients.

ABSTRACT: Migraine is a common neurovascular condition that may be linked to hyperhomocysteinemia. We have previously provided evidence that reduction of homocysteine with a vitamin supplementation can reduce the occurrence of migraine in women. The current study examined the occurrence of migraine in response to vitamin supplementation with a lower dose of folic acid.This was a 6 month randomised, double blinded placebo controlled trial of daily vitamin supplementation containing 1 mg of folic acid, 25 mg of Vitamin B6 and Vitamin B12, on reduction of homocysteine and the occurrence of migraine in 300 female patients diagnosed with migraine with aura.Vitamin supplementation with 1 mg of folic acid, did not significantly decrease homocysteine levels (P = 0.2). The treatment group did not show a significant decrease in the percentage of participants with high migraine disability, severity or frequency at the end of the 6 month intervention (P > 0.1).1 mg of folic acid in combination with vitamin B6 and B12 is less effective in reducing migraine associated symptoms compared to the previously tested dosage of 2 mg folic acid in combination with 25 mg of vitamin B6 and 400 μg of vitamin B12.


PROVIDER: S-EPMC4919187 | BioStudies | 2016-01-01


REPOSITORIES: biostudies

Similar Datasets

2015-01-01 | S-EPMC4381191 | BioStudies
2009-01-01 | S-EPMC2712772 | BioStudies
2015-01-01 | S-EPMC4565665 | BioStudies
2008-01-01 | S-EPMC2684623 | BioStudies
2015-11-16 | GSE74548 | GEO
1000-01-01 | S-EPMC3677457 | BioStudies
2016-01-01 | S-EPMC5295052 | BioStudies
2016-01-01 | S-EPMC4948058 | BioStudies
2018-01-01 | S-EPMC6283543 | BioStudies
2015-01-01 | S-EPMC4644301 | BioStudies